Emesson
Brand Name
Emesson
Generic Name
Ondansetron
Composition
Emesson 4mg/2ml Injection: Each 2ml ampoule contains:
Ondansetron (as HCL Dihydarte) ——-4mg
Emesson 8mg/4ml Injection: Each 4ml ampoule contains.
Ondansetron (as HCL Dihydrate) ——-8mg
Emesson 4mg Tablet: Each film-coated tablet contains:
Ondansetron HCL Dihydarte eq. to Ondansetron 4mg
Emesson 8mg Tablet: Each film-coated tablet contains:
Ondansetron HCL Dihydarte eq. to Ondansetron 8mg
Emesson Oral Solution: Each 5ml contains:
Ondansetron as HCL Dihydarte eq. to Ondansetron 4mg
Indications
In adults it is indicated for:
- Prevention & Treatment of nausea & vomiting induced by cytotoxic chemotherapy & radiotherapy.
- Prevention & Treatment of post-operative nausea & vomiting (PONV)
In Pediatric Population it is indicated for the:
- Management of chemotherapy-induced nausea & vomiting (CINV) in children aged ≥ 6 months.
- Prevention & treatment of PONV in children aged ≥ 1 month.
Presentation
Emesson Injection 8mg: Pack of Tray Blister 1’s & 5’s
Emesson Injection 4mg: Pack of Tray Blister of 1’s & 5’s
Emesson 4mg Tablets: Alu. Alu Blister pack of 1*10s.
Emesson 8mg Tablets: Alu. Alu Blister pack of 1*10s.
